Citius Oncology Inc (NASDAQ:CTOR) has seen 1.49 shares traded in the last trading session. The company, currently valued at $188.18M, closed the last trade at $1.55 per share which meant it lost -$1.45 on the day or 2.63% during that session. The CTOR stock price is -3061.29% off its 52-week high price of $49.00 and 64.52% above the 52-week low of $0.55. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.66 million shares traded. The 3-month trading volume is 13.50 shares.

Citius Oncology Inc (NASDAQ:CTOR) trade information

Sporting 2.63% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the CTOR stock price touched $1.55 or saw a rise of 54.81%. Year-to-date, Citius Oncology Inc shares have moved -76.48%, while the 5-day performance has seen it change 78.91%. Over the past 30 days, the shares of Citius Oncology Inc (NASDAQ:CTOR) have changed 195.51%. Short interest in the company has seen 25500.0 shares shorted with days to cover at 0.52.

Citius Oncology Inc (CTOR) estimates and forecasts

The company’s shares have gained 139.09% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -537.43% – over the past 5 years.

CTOR Dividends

Citius Oncology Inc is expected to release its next earnings report on 2025-May-14 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Citius Oncology Inc (NASDAQ:CTOR)’s Major holders

Insiders own 95.08% of the company shares, while shares held by institutions stand at 0.76% with a share float percentage of 15.38%. Investors are also buoyed by the number of investors in a company, with Citius Oncology Inc having a total of 9.0 institutions that hold shares in the company.